Glenmede Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,636
Closed -$239K 1383
2024
Q4
$239K Buy
3,636
+22
+0.6% +$1.45K ﹤0.01% 1182
2024
Q3
$254K Buy
+3,614
New +$254K ﹤0.01% 1158
2020
Q4
Sell
-537
Closed -$40K 1337
2020
Q3
$40K Buy
537
+76
+16% +$5.66K ﹤0.01% 1384
2020
Q2
$56K Buy
461
+147
+47% +$17.9K ﹤0.01% 1284
2020
Q1
$26K Hold
314
﹤0.01% 1947
2019
Q4
$26K Hold
314
﹤0.01% 1947
2019
Q3
$21 Sell
314
-68
-18% -$5 ﹤0.01% 2014
2019
Q2
$32 Buy
382
+40
+12% +$3 ﹤0.01% 1882
2019
Q1
$30 Sell
342
-2
-0.6% ﹤0.01% 1913
2018
Q4
$29 Buy
+344
New +$29 ﹤0.01% 1823
2018
Q3
Sell
-314
Closed -$30K 1483
2018
Q2
$30K Sell
314
-17,206
-98% -$1.64M ﹤0.01% 1600
2018
Q1
$1.56M Hold
17,520
0.01% 699
2017
Q4
$1.56M Buy
17,520
+622
+4% +$55.5K 0.01% 699
2017
Q3
$1.57M Buy
16,898
+589
+4% +$54.8K 0.01% 696
2017
Q2
$1.43M Hold
16,309
0.01% 703
2017
Q1
$1.43M Sell
16,309
-110
-0.7% -$9.65K 0.01% 703
2016
Q4
$1.36M Sell
16,419
-143
-0.9% -$11.8K 0.01% 689
2016
Q3
$1.53M Sell
16,562
-77
-0.5% -$7.12K 0.01% 676
2016
Q2
$1.29M Buy
16,639
+114
+0.7% +$8.86K 0.01% 702
2016
Q1
$1.36M Sell
16,525
-350
-2% -$28.8K 0.01% 682
2015
Q4
$1.77M Hold
16,875
0.01% 640
2015
Q3
$1.78M Sell
16,875
-16
-0.1% -$1.69K 0.01% 619
2015
Q2
$2.31M Sell
16,891
-319
-2% -$43.6K 0.02% 550
2015
Q1
$2.14M Hold
17,210
0.02% 581
2014
Q4
$1.56M Buy
17,210
+1,110
+7% +$100K 0.01% 627
2014
Q3
$1.16M Hold
16,100
0.01% 651
2014
Q2
$1M Hold
16,100
0.01% 700
2014
Q1
$1.1M Buy
16,100
+4,400
+38% +$300K 0.01% 670
2013
Q4
$823K Hold
11,700
0.01% 728
2013
Q3
$844K Hold
11,700
0.01% 696
2013
Q2
$652K Buy
+11,700
New +$652K 0.01% 717